Reversing the negative effect of adenosine A1 receptor-targeted immunometabolism modulation on melanoma by a co-delivery nanomedicine for self-activation of anti-PD-L1 DNAzyme

Authors:
  • JGJia Guo
    Jia Guo
  • PLPeng Liu
    Peng Liu
  • BWBenliang Wei
    Benliang Wei
  • YPYing Peng
    Ying Peng
  • JDJinsong Ding
    Jinsong Ding
  • HZHailun Zhang
    Hailun Zhang
  • GZGuanxiong Zhang
    Guanxiong Zhang
  • JSJuan Su
    Juan Su
  • HLHong Liu
    Hong Liu
  • WZWenhu Zhou
    Wenhu Zhou
  • XCXiang Chen
    Xiang Chen

Abstract
No abstract available
Funding Information
  • Key Technologies Research and Development Program (2019YFE0120800)
  • Key Technologies Research and Development Program (2019YFA0111600)
  • Youth Science Fund Project (82022060)
  • National Natural Science Foundation of China (81974478)
  • National Natural Science Foundation of China (U1903125)
  • National Natural Science Foundation of China (82173009)
  • National Natural Science Foundation of China (U22A20329)
  • Science and Technology Program of Hunan Province (2022RC3004)
  • Science and Technology Innovative Research Team in Higher Educational Institutions of Hunan Province (2021RC3020)
  • Science Fund for Creative Research Groups (82221002)
  • Science Fund for Creative Research Groups (8213000715)
  • National Key Research and Development Program of China
  • Natural Science Foundation of Henan Province
  • Natural Science Foundation of Hunan Province (2021JJ20084)

This publication has 57 references indexed in Scilit: